abstract |
The present invention is an experimental model animal that develops human hypertrophic cardiomyopathy, which is produced by continuously administering a potassium channel inhibitor or a potassium channel inhibitor and an antibody to the whole body or heart of the animal. A model animal is provided. This animal can be used for elucidating the pathophysiology of hypertrophic cardiomyopathy and screening for prophylactic / therapeutic drugs, and is extremely useful as an experimental animal. |